PT  - JOURNAL ARTICLE
AU  - Khan Chowdhury, Mohammad Rocky
AU  - Stub, Dion
AU  - Karim, Md Nazmul
AU  - Brennan, Angela
AU  - Reid, Christopher M.
AU  - Nanayakkara, Shane
AU  - Lefkovits, Jeffrey
AU  - Moni, Mohammad Ali
AU  - Islam, Md Shofiqul
AU  - Chew, Derek P.
AU  - Dinh, Diem
AU  - Billah, Baki
TI  - Machine learning approaches to predict 30-day mortality following percutaneous coronary intervention in an Australian population
AID  - 10.1101/2025.03.01.25323134
DP  - 2025 Jan 01
TA  - medRxiv
PG  - 2025.03.01.25323134
4099  - http://medrxiv.org/content/early/2025/03/06/2025.03.01.25323134.short
4100  - http://medrxiv.org/content/early/2025/03/06/2025.03.01.25323134.full
AB  - Background PCI is an effective treatment for coronary artery disease. Pre-procedural 30-day mortality post-PCI risk prediction aids in clinical decision-making and benchmarking hospital performance. This study aimed to identify pre-procedural factors to predict the risk of 30-day mortality following Percutaneous Coronary Intervention (PCI) using machine learning (ML) approaches.Methods The study analysed 93,055 consecutive PCI procedures from the Victorian Cardiac Outcomes Registry (VCOR) in Australia to develop a pre-procedural 30-day mortality prediction model. Five ML approaches—Adaptive Booster (AdB), Decision Tree (DT), Gradient Booster (GB), Random Forest (RF), and Extreme Gradient Booster (XGB) were employed, utilizing Logistic Regression (LR) for comparison. Model performance was evaluated using k-fold cross-validation, with metrics including sensitivity, specificity, accuracy, ROC curve, Brier score, and calibration curve.Results The study showed that the RF model outperformed other ML models in predicting 30-day mortality, achieving accuracy of 98.4% and a ROC of 94.3%. Utilizing the SHapley Additive exPlanations method, the RF model identified cardiogenic shock, ejection fraction, acute coronary syndrome, estimated GFR, cardiac arrest, age, mechanical ventricular support, complex lesion, lesion location, BMI, sex, and diabetes as the variables that were associated with 30-day mortality post-PCI. In comparison, the traditional LR model exhibited an accuracy of 98.2% and a ROC of 92.9%.Conclusion A 30-day mortality post-PCI risk prediction model was developed with high accuracy using a ML method. It’s essential to underscore the need for further validation with external data to ensure the applicability of the model to other populations.WHAT IS ALREADY KNOWN ON THIS TOPICA risk-adjustment model for an Australian PCI patient population was previously developed to predict 30-day mortality using traditional regression model.Medical knowledge, patient characteristics, and clinical practices evolve over time, requiring frequent model updates to reflect new evidence, guidelines, and interventionsWHAT THIS STUDY ADDSA machine learning (ML)-based preprocedural risk prediction model for 30-day mortality following percutaneous coronary intervention (PCI) was developed.The ML-based model was compared with the traditional regression model. HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICYRisk prediction models aid clinical decision-making, enhance patient counselling, improve care quality, inform healthcare policies, and advance research.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:De-identified individual-level dataI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsPCIPercutaneous coronary interventionAdBAdaptive BoosterDTDecision TreeGBGradient BoosterRFRandom ForestXGBExtreme Gradient BoosterLRLogistic RegressioneGFRestimated Glomerular filtration rateACSAcute coronary syndromeOHCAOut-of-hospital cardiac arrestPVDPeripheral vascular diseaseCVDCerebrovascular diseaseCTOChronic total occlusionCABGcoronary artery bypass graftingROCReceiver operating characteristicSTEMIST-elevated myocardial infractionSHAPSHapley Additive exPlanationsBMIBody mass indexMLMachine LearningVCORVictorian cardiac outcome registryMICEMultiple Imputations by Chained EquationsTIMIThrombolysis in Myocardial Infarction